Home/Hedge Fund Intelligence/Bicara Therapeutics Inc.
Nasdaq: BCAXStockForm 13F30 Jun 2026

Hedge funds that hold Bicara Therapeutics Inc. Nasdaq: BCAX

CUSIP 055477103 · who reports it, how much, and how much it matters to them

16 of the 720 hedge fund managers we track reported shares of Bicara Therapeutics Inc. (Nasdaq: BCAX) on Form 13F for 30 June 2026. Between them they reported USD 430m. The largest position belongs to Ra Capital Management, at USD 215m. The manager with the most riding on it is Palo Alto Investors, where it is 2.3% of the reported book.

Managers reporting it16of 720 we track
Value they reportUSD 430mshares only, 30 Jun 2026
Funds they run143with a file on PPLI.com
Largest positionUSD 215mRa Capital Management
Typical weight0.0%median share of a manager's book
Heaviest weight2.3%Palo Alto Investors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

16 managers, USD 430m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Bicara Therapeutics Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Ra Capital Management1 fund on PPLI.comUSD 215m1.9%
2Deep Track Capital1 fund on PPLI.comUSD 122m1.8%
3Palo Alto Investors6 funds on PPLI.comUSD 16m2.3%
4Rock Springs Capital Management2 funds on PPLI.comUSD 16m0.8%
5D. E. Shaw & Co.15 funds on PPLI.comUSD 15m0.0%
6Walleye Capital8 funds on PPLI.comUSD 10m0.0%
7Dafna Capital Management6 funds on PPLI.comUSD 8.5m1.6%
8Millennium Management6 funds on PPLI.comUSD 7.8m0.0%
9Citadel Advisors32 funds on PPLI.comUSD 6.3m0.0%
10Orbimed Advisors1 fund on PPLI.comUSD 5.7m0.1%
11Hudson Bay Capital Management8 funds on PPLI.comUSD 3.1m0.0%
12Burkehill Global Management5 funds on PPLI.comUSD 1.5m0.1%
13Two Sigma Investments35 funds on PPLI.comUSD 1.4m0.0%
14Aquatic Capital Management3 funds on PPLI.comUSD 538,0000.0%
15Engineers Gate Manager1 fund on PPLI.comUSD 499,0000.0%
16Voleon Capital Management13 funds on PPLI.comUSD 349,0000.0%
Next: where it matters most
Where it matters most

For Palo Alto Investors it is 2.3% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Palo Alto InvestorsUSD 16m2.3%
2Ra Capital ManagementUSD 215m1.9%
3Deep Track CapitalUSD 122m1.8%
4Dafna Capital ManagementUSD 8.5m1.6%
5Rock Springs Capital ManagementUSD 16m0.8%
6Orbimed AdvisorsUSD 5.7m0.1%
7Burkehill Global ManagementUSD 1.5m0.1%
8Walleye CapitalUSD 10m0.0%
9Aquatic Capital ManagementUSD 538,0000.0%
10Hudson Bay Capital ManagementUSD 3.1m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Bicara Therapeutics Inc.

What is the ticker symbol of Bicara Therapeutics Inc.?

Bicara Therapeutics Inc. trades under the symbol BCAX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 055477103.

Which hedge funds own Bicara Therapeutics Inc. (Nasdaq: BCAX)?

16 of the 720 hedge fund managers PPLI.com tracks reported Bicara Therapeutics Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 215m), Deep Track Capital (USD 122m), Palo Alto Investors (USD 16m), Rock Springs Capital Management (USD 16m) and D. E. Shaw & Co. (USD 15m).

How many hedge funds hold Bicara Therapeutics Inc.?

16 managers in our coverage reported it, and between them they run 143 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Bicara Therapeutics Inc.?

Palo Alto Investors, where the position was 2.3% of the reported 13F book at 30 June 2026.

Does this show who is short Bicara Therapeutics Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Bicara Therapeutics Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.